Your browser doesn't support javascript.
loading
Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice.
Seedorf, Klaus; Weber, Csaba; Vinson, Cedric; Berger, Sylvie; Vuillard, Laurent-Michel; Kiss, Arpad; Creusot, Stephanie; Broux, Olivier; Geant, Anne; Ilic, Catherine; Lemaitre, Karine; Richard, Johann; Hammoutene, Adel; Mahieux, Julien; Martiny, Virginie; Durand, Didier; Melchiore, Fabien; Nyerges, Miklos; Paradis, Valerie; Provost, Nicolas; Duvivier, Valérie; Delerive, Philippe.
Afiliação
  • Seedorf K; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Weber C; Servier Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary.
  • Vinson C; Technologie Servier, 27 Rue Eugène Vignat, 45000 Orleans, France.
  • Berger S; Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
  • Vuillard LM; Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
  • Kiss A; Servier Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary.
  • Creusot S; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Broux O; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Geant A; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Ilic C; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Lemaitre K; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Richard J; Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
  • Hammoutene A; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Mahieux J; Université Paris Cité, Inserm, Centre de Recherche sur l'inflammation, F-75018 Paris, France.
  • Martiny V; Technologie Servier, 27 Rue Eugène Vignat, 45000 Orleans, France.
  • Durand D; Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
  • Melchiore F; Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
  • Nyerges M; Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France.
  • Paradis V; Servier Research Institute of Medicinal Chemistry, Záhony u. 7., H-1031 Budapest, Hungary.
  • Provost N; Département de Pathologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
  • Duvivier V; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
  • Delerive P; Cardiovascular and Metabolic Diseases Research, Institut de Recherches Servier, Suresnes, France.
JHEP Rep ; 5(4): 100651, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36866391

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JHEP Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JHEP Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França